| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |